✨ Free AI Report
Agile Therapeutics Inc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Agile Therapeutics Inc
Company Research

Agile Therapeutics Inc: Business Overview, Financials & Competitive Analysis

Agile Therapeutics Inc scores 3/10 on the AskCyborg Cyborg Score (Challenged). Agile's acquisition by Insud suggests the contraceptive patch market remains challenged for smaller entrants despite innovation potential. The company was acquired in August 2024 at a relatively modest valuation ($45M), indicating limited commercial success or market traction. While Twirla represents a differentiated women's health product, the company struggled to.

What is Agile Therapeutics Inc's industry? Agile Therapeutics Inc (agiletherapeutics.com) operates in Pharmaceuticals. AskCyborg classifies Agile Therapeutics Inc under Pharmaceuticals in its company registry.

Agile Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of prescription contraceptive products for women. The company was acquired by Insud Pharma, S.L. in August 2024...

3/ 10Challenged

Cyborg Score thesis

Agile's acquisition by Insud suggests the contraceptive patch market remains challenged for smaller entrants despite innovation...

Read the full analyst-debate transcript →
Industry Pharmaceuticals
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest Agile Therapeutics Inc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Agile Therapeutics Inc

AskCyborg analysts argue the bull and bear cases for Agile Therapeutics Inc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Agile Therapeutics Inc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Agile Therapeutics Inc Overview

Pro stress-test →

Agile Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of prescription contraceptive products for women. The company was acquired by Insud Pharma, S.L. in August 2024 for an enterprise value of approximately $45 million, with shareholders receiving $1.52 per share in cash.

Strategic Profile

Pro stress-test →

The company's lead product candidate is Twirla, a once-weekly contraceptive patch. Following the acquisition, Agile combined with Insud Pharma's US subsidiary, Exeltis USA, Inc., expanding their women's health and contraceptive portfolio. Agile now operates as an indirect subsidiary of Insud and has ceased to be listed on any public market.

Competitive Landscape

Pro stress-test →

Agile competed in the women's hormonal contraceptive market against established oral contraceptive brands (e.g., Yaz, Ortho-Cyclen) and other contraceptive delivery methods. The company's Twirla patch technology differentiated on convenience (once-weekly dosing) compared to daily oral pills, positioning against products like Xulane (norelgestromin/ethinyl estradiol) from Allergan. However, limited market penetration and inability to sustain independent operations led to acquisition.

Industry Context

Agile Therapeutics Inc operates in Pharmaceuticals.

Key facts

Headquarters: Princeton, US

What the analysts stress-tested

The top findings that survived the multi-agent debate for Agile Therapeutics Inc.

  • (August 2024) Acquired by Spain-based Insud Pharma for $45M enterprise value, ending public status
  • Twirla—once-weekly transdermal contraceptive patch—represents alternative to oral contraceptives but faced commercialization headwinds
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • August 2024Acquisition completed by Insud Pharma, S.L.; company delisted from OTC markets and became private subsidiary
  • June 2024Merger agreement signed with Insud Pharma
  • +1 moreTrack every material event for Agile Therapeutics Inc as it happens. Explore monitoring →
Get alerted when Agile Therapeutics Inc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

XulaneWeekly contraceptive patch→YazOral hormonal contraceptive→Ortho-CyclenOral hormonal contraceptive→

Compare Agile Therapeutics Inc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Agile Therapeutics Inc operates in Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Agile Therapeutics Inc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Agile Therapeutics Inc and its top competitor on Cyborg Score”
“What did Agile Therapeutics Inc do this quarter?”
“Is Agile Therapeutics Inc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Agile Therapeutics Inc do?+
Agile Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of prescription contraceptive products for women. The company was acquired by Insud Pharma, S.L. in August 2024...
What is Agile Therapeutics Inc's Cyborg Score?+
Agile Therapeutics Inc has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Agile Therapeutics Inc's main competitors?+
Named competitors include Xulane, Yaz, Ortho-Cyclen. The full competitive landscape is in the AskCyborg report.
How can I get the full Agile Therapeutics Inc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Agile Therapeutics Inc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Agile Therapeutics Inc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Novartis AG7Recordati Industria Chimica e Farmaceutica SpA6CSPC Innovation Pharmaceutical Co., Ltd.